Antithrombotic/Antiplatelet Treatment in Transcatheter Structural Cardiac Interventions—PFO/ASD/LAA Occluder and Interatrial Shunt Devices

Transcatheter interventions enable safe and efficient treatment of various structural heart diseases. However, therapy does not finished with the end of the procedure. Device thrombosis is a possible serious complication. Therefore, careful patient management should include optimal antiplatelet or a...

Full description

Bibliographic Details
Main Authors: Anna Olasinska-Wisniewska, Marek Grygier
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-06-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fcvm.2019.00075/full
_version_ 1818920700294987776
author Anna Olasinska-Wisniewska
Marek Grygier
author_facet Anna Olasinska-Wisniewska
Marek Grygier
author_sort Anna Olasinska-Wisniewska
collection DOAJ
description Transcatheter interventions enable safe and efficient treatment of various structural heart diseases. However, therapy does not finished with the end of the procedure. Device thrombosis is a possible serious complication. Therefore, careful patient management should include optimal antiplatelet or antithrombotic medication to enhance safe and complete endothelial coverage of the implanted device. In case of thrombus formation careful diagnostic evaluation and prompt treatment is crucial. This paper provides an update to current knowledge and understanding of prevention and management of device related thrombosis.
first_indexed 2024-12-20T01:25:55Z
format Article
id doaj.art-dfe00b2699764914b389d94877a06e42
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-12-20T01:25:55Z
publishDate 2019-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-dfe00b2699764914b389d94877a06e422022-12-21T19:58:14ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2019-06-01610.3389/fcvm.2019.00075448591Antithrombotic/Antiplatelet Treatment in Transcatheter Structural Cardiac Interventions—PFO/ASD/LAA Occluder and Interatrial Shunt DevicesAnna Olasinska-WisniewskaMarek GrygierTranscatheter interventions enable safe and efficient treatment of various structural heart diseases. However, therapy does not finished with the end of the procedure. Device thrombosis is a possible serious complication. Therefore, careful patient management should include optimal antiplatelet or antithrombotic medication to enhance safe and complete endothelial coverage of the implanted device. In case of thrombus formation careful diagnostic evaluation and prompt treatment is crucial. This paper provides an update to current knowledge and understanding of prevention and management of device related thrombosis.https://www.frontiersin.org/article/10.3389/fcvm.2019.00075/fullantithromboticantiplateletASDPFO (patent foramen ovale)LAA (left atrial appendage) closureInteratrial shunt device
spellingShingle Anna Olasinska-Wisniewska
Marek Grygier
Antithrombotic/Antiplatelet Treatment in Transcatheter Structural Cardiac Interventions—PFO/ASD/LAA Occluder and Interatrial Shunt Devices
Frontiers in Cardiovascular Medicine
antithrombotic
antiplatelet
ASD
PFO (patent foramen ovale)
LAA (left atrial appendage) closure
Interatrial shunt device
title Antithrombotic/Antiplatelet Treatment in Transcatheter Structural Cardiac Interventions—PFO/ASD/LAA Occluder and Interatrial Shunt Devices
title_full Antithrombotic/Antiplatelet Treatment in Transcatheter Structural Cardiac Interventions—PFO/ASD/LAA Occluder and Interatrial Shunt Devices
title_fullStr Antithrombotic/Antiplatelet Treatment in Transcatheter Structural Cardiac Interventions—PFO/ASD/LAA Occluder and Interatrial Shunt Devices
title_full_unstemmed Antithrombotic/Antiplatelet Treatment in Transcatheter Structural Cardiac Interventions—PFO/ASD/LAA Occluder and Interatrial Shunt Devices
title_short Antithrombotic/Antiplatelet Treatment in Transcatheter Structural Cardiac Interventions—PFO/ASD/LAA Occluder and Interatrial Shunt Devices
title_sort antithrombotic antiplatelet treatment in transcatheter structural cardiac interventions pfo asd laa occluder and interatrial shunt devices
topic antithrombotic
antiplatelet
ASD
PFO (patent foramen ovale)
LAA (left atrial appendage) closure
Interatrial shunt device
url https://www.frontiersin.org/article/10.3389/fcvm.2019.00075/full
work_keys_str_mv AT annaolasinskawisniewska antithromboticantiplatelettreatmentintranscatheterstructuralcardiacinterventionspfoasdlaaoccluderandinteratrialshuntdevices
AT marekgrygier antithromboticantiplatelettreatmentintranscatheterstructuralcardiacinterventionspfoasdlaaoccluderandinteratrialshuntdevices